Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lang, Anthony E.
1984.
Treatment of Parkinson’s disease with agents other than Levodopa and Dopamine Agonists: controversies and new approaches.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 11,
Issue. S1,
p.
210.
1984.
COMMUNICATIONS.
British Journal of Pharmacology,
Vol. 81,
Issue. S1,
Birkmayer, W.
Riederer, P.
Linauer, W.
and
Knoll, J.
1984.
L-deprenyl plus l-phenylalanine in the treatment of depression.
Journal of Neural Transmission,
Vol. 59,
Issue. 1,
p.
81.
Norman, Trevor R.
Ames, David
Burrows, Graham D.
and
Davies, Brian
1985.
A controlled study of a specific MAO a reversible inhibitor (R011-1163) and amitriptyline in depressive illness.
Journal of Affective Disorders,
Vol. 8,
Issue. 1,
p.
29.
Hazelhoff, Bernard
De Vries, Jan B.
Dijkstra, Durk
de Jong, Wybren
and
Horn, Alans S.
1985.
The neuropharmacological profile of N-methyl-N-propargyl-2-aminotetralin: a potent monoamine oxidase inhibitor.
Naunyn-Schmiedeberg's Archives of Pharmacology,
Vol. 330,
Issue. 1,
p.
50.
Youdim, M.B.H.
and
Finberg, J.P.M.
1985.
Preclinical Psychopharmacology.
p.
35.
Zimmerman, Mark
Coryell, William
and
Pfohl, Bruce
1985.
The treatment validity of DSM-III melancholic subtyping.
Psychiatry Research,
Vol. 16,
Issue. 1,
p.
37.
Pare, C. M. B.
1985.
The Present Status of Monoamine Oxidase Inhibitors.
British Journal of Psychiatry,
Vol. 146,
Issue. 6,
p.
576.
Pare, C.M.B.
Al Mousawi, M.
Sandler, M.
and
Glover, Vivette
1985.
Attempts to attenuate the ‘cheese effect’ combined drug therapy in depressive illness.
Journal of Affective Disorders,
Vol. 9,
Issue. 2,
p.
137.
Garrick, Nancy A.
Seppala, Timo
Linnoila, Markku
and
Murphy, Dennis L.
1985.
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone.
Psychopharmacology,
Vol. 86,
Issue. 3,
p.
265.
Liebowitz, Michael R.
Karoum, Farouk
Quitkin, Frederic M.
Davies, Sharon O.
Schwartz, David
Levitt, Morton
and
Linnoila, Markku
1985.
Biochemical effects of l-deprenyl in atypical depressives.
Biological Psychiatry,
Vol. 20,
Issue. 5,
p.
558.
Simpson, George M.
Frederickson, Eric
Palmer, Ruby
Pi, Edmond
Sloane, R.Bruce
and
White, Kerrin
1985.
Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: Implications for clinical use.
Biological Psychiatry,
Vol. 20,
Issue. 6,
p.
684.
Sunderland, Trey
Mueller, Edward A.
Cohen, Robert M.
Jimerson, David C.
and
Pickar, David
1985.
Tyramine pressor sensitivity changes during deprenyl treatment.
Psychopharmacology,
Vol. 86,
Issue. 4,
p.
432.
Pare, C. M. B.
and
Mendis, N.
1985.
Psychiatry the State of the Art.
p.
105.
Moises, H. W.
Waldmeier, P.
and
Beckmann, H.
1986.
Urinary phenylethylamine correlates positively with hypomania, and negatively with depression, paranoia, and social introversion on the MMPI.
European Archives of Psychiatry and Neurological Sciences,
Vol. 236,
Issue. 2,
p.
83.
Dowson, J. H.
1987.
Monoamine Oxidase Enzymes.
p.
121.
Murphy, D. L.
Sunderland, T.
Garrick, N. A.
Aulakh, C. S.
and
Cohen, R. M.
1987.
Clinical Pharmacology in Psychiatry.
p.
135.
Sunderland, T.
Tariot, P. N.
Cohen, R. M.
Newhouse, P. A.
Mellow, A. M.
Mueller, E. A.
and
Murphy, D. L.
1987.
Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
Psychopharmacology,
Vol. 91,
Issue. 3,
p.
293.
Pare, C M B
1987.
Monoamine Oxidase Inhibitors in the Treatment of Affective Disorders.
Psychiatric Annals,
Vol. 17,
Issue. 5,
p.
309.
Tariot, P.N.
Sunderland, T.
Weingartner, H.
Murphy, D.L.
Welkowitz, J.A.
Thompson, K.
and
Cohen, R.M.
1987.
Cognitive effects of l-deprenyl in Alzheimer's disease.
Psychopharmacology,
Vol. 91,
Issue. 4,
p.
489.
eLetters
No eLetters have been published for this article.